1-17033060-C-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM5PP3_ModeratePP5_Very_Strong
The NM_003000.3(SDHB):c.286G>A(p.Gly96Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000372 in 1,612,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 15/26 in silico tools predict a damaging outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G96C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003000.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SDHB | ENST00000375499.8 | c.286G>A | p.Gly96Ser | missense_variant, splice_region_variant | Exon 3 of 8 | 1 | NM_003000.3 | ENSP00000364649.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251244 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460038Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726470 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 31579262, 24436918, 28973655, 29386252, 25972245, 26273102, 28152038, 28374168, 19802898, 23083876, 33300499, 32741965, 34906457) -
- -
Hereditary pheochromocytoma-paraganglioma Pathogenic:2
- -
The c.286G>A (p.Gly96Ser) variant in the SDHB gene is located on the exon 3 and is predicted to replace glycine with serine at codon 96 (p.Gly96Ser). The variant has been reported in multiple individuals with paragangliomas/pheochromocytoma (PMID: 34906457, 19802898, 24436918, 28374168) and 2 unrelated individuals with renal cancer (PMID: 23083876, 28973655). The variant is predicted to cause splicing donor loss (SpliceAI delta score: 0.77), resulting in alternative splicing and disrupted protein product. Loss-of-function variants of SDHB are known to be pathogenic (PMID: 16258955, 19389109, 28490599). The variant is reported in ClinVar (ID: 142111). The variant is rare in the general population according to gnomAD (3/251244). Computational prediction algorithms suggest a deleterious impact for this variant (REVEL score 0.967). Therefore, the c.286G>A (p.Gly96Ser) variant of SDHB has been classified as likely pathogenic. -
Pheochromocytoma/paraganglioma syndrome 4 Pathogenic:1
This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 23083876, 24436918, 30201732, 34906457, 29386252]. -
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Pheochromocytoma/paraganglioma syndrome 4 Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 96 of the SDHB protein (p.Gly96Ser). This variant also falls at the last nucleotide of exon 3, which is part of the consensus splice site for this exon. This variant is present in population databases (rs587782243, gnomAD 0.003%). This missense change has been observed in individuals with clinical features of hereditary paraganglioma and/or pheochromocytoma syndrome (PMID: 2308387, 19802898, 24436918, 28374168, 29386252; external communications, internal data). ClinVar contains an entry for this variant (Variation ID: 142111). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this missense change is associated with inconclusive levels of altered splicing (internal data). For these reasons, this variant has been classified as Pathogenic. -
Gastrointestinal stromal tumor Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.G96S pathogenic mutation (also known as c.286G>A), located in coding exon 3 of the SDHB gene, results from a G to A substitution at nucleotide position 286. This change occurs in the last base pair of coding exon 3, which makes it likely to have some effect on normal mRNA splicing. In addition to potential splicing impact, this alteration changes the glycine at codon 96 to serine, an amino acid with similar properties. This variant has been identified in multiple affected individuals with SDHB-associated tumors (Jochmanova I et al. J. Cancer Res. Clin. Oncol., 2017 Aug;143:1421-1435; Sridhara SK et al. J Neurol Surg B Skull Base, 2013 Aug;74:236-40; Ricketts CJ et al. J Urol. 2012 Dec;188(6):2063-71; Ricketts CJ et al. Hum Mutat. 2010 Jan;31(1):41-51; Ambry internal data). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site; however, direct evidence is insufficient at this time (Ambry internal data). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at